Literature DB >> 19635397

Systemic therapies for squamous cell carcinoma of the head and neck.

Sandra E Kurtin1.   

Abstract

OBJECTIVES: To discuss current clinical recommendations for treatment of squamous cell carcinoma of the head and neck (SCCHN), to identify common toxicities associated with combined chemoradiotherapy or chemotherapy alone, and describe strategies for management of the most common treatment-related toxicities. DATA SOURCES: Current research, published literature, National Comprehensive Cancer Network Clinical Practice Guidelines, American Society of Clinical Oncology, and Oncology Nursing Society.
CONCLUSION: Advances in options for systemic therapy for SCCHN have provided hope for patients with this disease. However, effective management of these patients requires a proactive and persistent multidisciplinary treatment approach, including toxicity management. IMPLICATIONS FOR NURSING PRACTICE: Careful evaluation of each patient before initiating treatment with the goals of therapy reviewed by the multidisciplinary team, the patient, and the caregivers, will allow selection of the most appropriate treatment plan. The goals of therapy should provide guidance in balancing tumor response, toxicity (both acute and late effects), survival, and quality of life.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635397     DOI: 10.1016/j.soncn.2009.05.001

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  3 in total

1.  Prevalence and correlates of symptoms and uncertainty in illness among head and neck cancer patients receiving definitive radiation with or without chemotherapy.

Authors:  Mary Ellen Haisfield-Wolfe; Deborah B McGuire; Karen Soeken; Jeanne Geiger-Brown; Bruce De Forge; Mohan Suntharalingam
Journal:  Support Care Cancer       Date:  2011-10-04       Impact factor: 3.603

2.  Carrier-based intralymphatic cisplatin chemotherapy for the treatment of metastatic squamous cell carcinoma of the head & neck.

Authors:  Shuang Cai; Yumei Xie; Neal M Davies; Mark S Cohen; M Laird Forrest
Journal:  Ther Deliv       Date:  2010-08

3.  Transcatheter arterial chemoembolization is safe and effective for patients with late-stage or recurrent oral carcinoma.

Authors:  Yonghua Bi; Tianfeng Du; Wenting Pan; Fan Tang; Yang Wang; Dechao Jiao; Xinwei Han; Jianzhuang Ren
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.